Rapid quantification of levosulpiride in human plasma using RP-HPLC-MS/MS for pharmacokinetic and bioequivalence study
- Authors
- Park, Jin-Hee; Park, Yoo-Sin; Rhim, Si-Youn; Kim, Hyun-Jin; Jhee, Ok-Hwa; Lee, Yun-Sik; Lee, Min-Ho; Shaw, Leslie M.; Kang, Ju-Seop
- Issue Date
- Dec-2009
- Publisher
- John Wiley & Sons Inc.
- Keywords
- levosulpiride; LC-MS/MS; pharmacokinetics; bioequivalence study
- Citation
- Biomedical Chromatography, v.23, no.12, pp 1350 - 1356
- Pages
- 7
- Indexed
- SCIE
SCOPUS
- Journal Title
- Biomedical Chromatography
- Volume
- 23
- Number
- 12
- Start Page
- 1350
- End Page
- 1356
- URI
- https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/175786
- DOI
- 10.1002/bmc.1260
- ISSN
- 0269-3879
1099-0801
- Abstract
- A rapid and validated method for analysis of levosulpiride in human plasma using liquid chromatography coupled to tandem mass spectrometry was developed. Levosulpiride and tiapride (IS, internal standard) were extracted from alkalized plasma samples with ethylacetate and separation by RP-HPLC. Detection was performed by positive ion electrospray ionization in multiple-reaction monitoring mode, monitoring the transitions m/z 342.1 -> m/z 112.2 and m/z 329.1 -> m/z 213.2, for quantification of levosulpiride and IS, respectively. The standard calibration curves showed good linearity within the range of 2-200 ng/mL (r(2) >= 0.9990). The lower limit of quantitation was 2 ng/mL. The retention times of levosulpiride (0.63 min) and IS (0.66 min) presented a significant time saving benefit of the proposed method. No significant metabolic compounds were found to interfere with the analysis. This method offered good precision and accuracy and was successfully applied for the pharmacokinetic and bioequivalence study of a 25 mg of levosulpiride tablet in 24 healthy Korean volunteers.
- Files in This Item
-
Go to Link
- Appears in
Collections - 서울 의과대학 > 서울 약리학교실 > 1. Journal Articles

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.